| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/11/1996 | CA2201119A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | CA2200629A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | CA2160100A1 Carbohydrate conjugates as inhibitors of cell adhesion |
| 04/10/1996 | EP0705903A1 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705902A1 17q-Linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705846A1 High molecular weight and low molecular weight fractions of von Willebrand factor |
| 04/10/1996 | EP0705845A2 Process of simultaneous removal of tumor necrosis factor and bacterial lipopolysaccharides from an aqueous solution |
| 04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
| 04/10/1996 | EP0705843A1 Bacteriocin from enterococcus feacium active against listeria monocytogenes |
| 04/10/1996 | EP0705842A2 Regulated genes by stimulation of chondrocytes with 1L-1beta |
| 04/10/1996 | EP0705841A1 Peptides havng antigenic activity against hepatitis A virus (HAV) |
| 04/10/1996 | EP0705436A1 Method for the diagnosis and analysis of breast carcinoma |
| 04/10/1996 | EP0705433A1 Compositions and methods for anti-addictive narcotic analgesis acivity screening and treatments |
| 04/10/1996 | EP0705346A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 04/10/1996 | EP0705342A1 Methods and compositions for modulating lipid content of plant tissues |
| 04/10/1996 | EP0705341A1 Hybrid receptor molecules |
| 04/10/1996 | EP0705340A1 Toxin gene from xenorhabdus nematophilus |
| 04/10/1996 | EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof |
| 04/10/1996 | EP0705338A1 Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s) |
| 04/10/1996 | EP0705337A1 Clostridium bifermentans dna fragment bearing genes coding for proteins linked to an insecticidal activity |
| 04/10/1996 | EP0705334A1 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 04/10/1996 | EP0705332A1 Construction and use of synthetic constructs encoding syndecan |
| 04/10/1996 | EP0705278A1 Apoptose inhibitor |
| 04/10/1996 | EP0705277A1 Prostaglandin receptor ep3 and dna encoding it |
| 04/10/1996 | EP0705276A1 Prostaglandin receptor fp and dna encoding it |
| 04/10/1996 | EP0705275A1 Asp?b28 insulin crystals |
| 04/10/1996 | EP0705274A1 Method and composition for treating thrombosis |
| 04/10/1996 | EP0705105A1 Metal chelates as spacer compounds in biologically active peptides |
| 04/10/1996 | EP0688316A4 Coupling method using selective amination of maleimide |
| 04/10/1996 | EP0612356B1 NUCLEOTIDE SEQUENCES HYBRIDIZING SPECIFICALLY WITH BACTERIAL STRAINS OF THE COMPLEX $i(MYCOBACTERIUM AVIUM-INTRACELLULARE) |
| 04/10/1996 | EP0537148B1 Purification of human interleukin-4 secreted from an escherichia coli mutant |
| 04/10/1996 | EP0507870B1 Polyhemoglobin stabilized by purine derivatives and glutathione |
| 04/10/1996 | EP0494135B1 Human "neu" related protein p100 and use of the same for detecting preneoplastic or neoplastic cells in a human |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | EP0289550B1 Vaccine for use in the therapeutic treatment of hsv |
| 04/10/1996 | CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 04/10/1996 | CN1120340A Separation of proteins |
| 04/10/1996 | CN1120315A 35/31 KDA subunit of the entamoeba histolytica adherence lectin |
| 04/10/1996 | CN1120047A New peptide compound and a process for the preparation thereof |
| 04/09/1996 | US5506344 Antibodies specific for BCL-2 gene product |
| 04/09/1996 | US5506343 Antibodies specific for the DF3 carcinoma associated antigen |
| 04/09/1996 | US5506341 Improving the therapeutic activity by incubating with buffer at neutral condition |
| 04/09/1996 | US5506340 Tumor necrosis factor inhibitors |
| 04/09/1996 | US5506339 Octapeptide analogs of somatostatin having threonine at the sixth position |
| 04/09/1996 | US5506337 Morpholino-subunit combinatorial library and method |
| 04/09/1996 | US5506218 Intravenously administering a protein and peptide free phospholipid and neutral lipid to the subject; prophylaxis |
| 04/09/1996 | US5506209 Product for inhibition of infection of mammalian cells by respiratory syncytial virus |
| 04/09/1996 | US5506208 Method for using synthetic analogs of thrombospondin for inhibiting angiogenesis activity |
| 04/09/1996 | US5506205 Treatment of diabetes |
| 04/09/1996 | US5506202 Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them |
| 04/09/1996 | US5506139 Vaccines, immunology |
| 04/09/1996 | US5506138 Recombinant vaccinia virus encoding cytochromes P-450 |
| 04/09/1996 | US5506131 Immortalized human cell lines containing exogenous cytochrome P450 genes |
| 04/09/1996 | US5506128 Recombinant infectious bovine rhinotracheitis virus |
| 04/09/1996 | US5506126 Diagnosis, therapy antigen |
| 04/09/1996 | US5506120 Method of producing peptides or proteins as fusion proteins |
| 04/09/1996 | US5506119 DNA encoding variant CD44 surface proteins associated with metastatic tumors |
| 04/09/1996 | US5506115 Reagent and method for determining activity of herpes protease |
| 04/09/1996 | US5506111 Method of immunological assaying of human osteocalcin, reagent and kit therefor, antibody to human osteocalcin, hybridoma producing said antibody, and method of producing it |
| 04/09/1996 | US5506110 Carrier for binding of anti-phospholipid antibodies, and immunoassay method using the same and a kit therefor |
| 04/09/1996 | US5506107 Selecting ligand agonists and antagonists |
| 04/09/1996 | US5506102 Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription |
| 04/09/1996 | US5506097 Contacting alzheimer amyloid beta-protein with ebelactone a or para-amidinophenylmethanesulfonyl fluoride |
| 04/09/1996 | US5505955 Anti-diarrheic product and method of treating rotavirus-associated infection |
| 04/09/1996 | US5505947 Attenuating mutations in Venezuelan Equine Encephalitis virus |
| 04/09/1996 | US5505941 Inoculating host with synthetic genetic engineered pathogen |
| 04/09/1996 | CA1338244C Purification of hemoglobin and methemoglobin by bioselective elution |
| 04/07/1996 | CA2159958A1 New toxoplasma gondii antigens |
| 04/07/1996 | CA2159957A1 Regulated genes by stimulation of chondrocytes with il-1.beta. |
| 04/04/1996 | WO1996020276A1 Tissue specific hypoxia regulated therapeutic constructs |
| 04/04/1996 | WO1996010182A1 Cell tests and diagnostic index for alzheimer's disease |
| 04/04/1996 | WO1996010092A1 Novel mammalian protein associated with uncontrolled cell division |
| 04/04/1996 | WO1996010089A1 Modification of peptide and protein |
| 04/04/1996 | WO1996010088A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 04/04/1996 | WO1996010087A1 Method for treatment of cancers by regulating the activity of ras proteins |
| 04/04/1996 | WO1996010086A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/04/1996 | WO1996010083A1 Novel pesticidal proteins and strains |
| 04/04/1996 | WO1996010082A1 Yeast with modified permeability |
| 04/04/1996 | WO1996010081A1 Vaccine composition comprising recombinant bcg expressing gp63 fusion protein |
| 04/04/1996 | WO1996010041A1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 04/04/1996 | WO1996010040A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 04/04/1996 | WO1996010039A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/04/1996 | WO1996010038A1 Multifunctional molecular complexes for gene transfer to cells |
| 04/04/1996 | WO1996008274A3 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents |
| 04/04/1996 | WO1996005315A3 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 04/04/1996 | WO1996004306A3 Muteins of mammalian cytokines |
| 04/04/1996 | WO1996003106A3 Allergenic peptides derived from poa pratensis |
| 04/04/1996 | WO1996000288A3 Class bi and ci scavenger receptors |
| 04/04/1996 | DE4434551A1 Peptide aus der Sequenz des hPTH (1-37) Peptides from the sequence of hPTH (1-37) |
| 04/04/1996 | CA2208599A1 Tissue specific hypoxia regulated therapeutic constructs |
| 04/04/1996 | CA2201122A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 04/04/1996 | CA2200973A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/04/1996 | CA2200963A1 Cell tests and diagnostic index for alzheimer's disease |
| 04/04/1996 | CA2200338A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/04/1996 | CA2197904A1 Deffective recombinant adenoviruses with inactivated iva2 gene |
| 04/03/1996 | EP0704532A2 Recombinant chimeric proteins and methods of use thereof |
| 04/03/1996 | EP0704530A2 A kanamycin resistance gene derived from microorganisms of the genus rhodococcus |
| 04/03/1996 | EP0704529A2 Vaccine against rabbit hemorrhagic disease virus |
| 04/03/1996 | EP0704528A2 Rabbit hemorrhagic disease virus (RHDV) recombinant capsids and proteins, diagnostic kits and vaccines containing them |
| 04/03/1996 | EP0704527A2 DNA sequences encoding biosynthetic insulin precursors and process for prepation of insulin |